SOSIP.v8.3 Binding Assay
Corresponding Organization :
Other organizations : Amsterdam University Medical Centers, University of Amsterdam, Scripps Research Institute, University of Southampton, Cornell University, University of Washington, Duke Medical Center
Protocol cited in 2 other protocols
Variable analysis
- Concentration of untagged 16055 SOSIP.v8.3 (2 µg/mL)
- Residual binding of mAbs (D11A.F9, D11A.F2, RM19R) after incubation with serum
- Coating of Galanthus nivalis lectin (20 µg/mL) in 0.1 M NaHCO3 pH 8.6
- Casein blocking buffer
- Dilution of rabbit sera (1:100) in TBS/2% skimmed milk/20% sheep serum
- Concentrations of mAbs (D11A.F9: 0.1 µg/mL; D11A.F2: 0.1 µg/mL; RM19R: 2 µg/mL) in TBS/2% skimmed milk/20% sheep serum
- Dilution of HRP-labeled donkey anti-human IgG (1:3000) in Casein
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!